Presented by: Aakriti Amin Anita Chiranjeev Sheena

Indias Leading Biotech enterprise.

Established in 1978. Focus on development of Biopharmaceuticals 1st in Asia & 16th in world in terms of revenue and marketcapitalization.

Syngene, Indias first biotech custom research company indrug discovery.

First company to manufacture human insulin using a Pichiaexpression system.

Indias first billion dollar biotech company.

BiographyKiran Mazumdar Shaw was

Born on March 23, 1953 in Bangalore.She did schooling from Bishop Cotton Girls Schooland Mount Carmel College at Bangalore.

After doing completing her B.Sc. in Zoology from

Bangalore University in 1973, she went to Ballarat University in Melbourne, Australia and qualified her masters.

The journey begins Collaborated with Irish firm Biocon international.

Kiran owned 70% and Auchinloss (biocon int.) owned 30% ofequity.

Started Biocon India from her garage. Initial Capital Rs/-10,000. Started extracting enzyme (papa in) from papaya & isinglass(fish moss)

Export to Irish firm Novel product patenting.

The BrandDynamic Helix or Dynalix

Multiple associations like DNA helix, molecules,inter locking Bs (Biocon & Biotech) About Branding

To convey innovation, quality, reliability,distinctiveness .

Pale blue packaging was chosen to stand out amongstd. white packages.

Products include Biopharmaceuticals

Anti-Diabetic Agents Anti-Hypertensive Agents Anti-inflammatory Agents

Anti

oxidants Cardiovascular Agents Digestive Aid

Enzymes Haemostatic Agents Hepatoprotective AgentsImmuno suppressants Nutraceuticals Enzymes Amylases Cellulases Esterases Glucanases Hemicellulases/ Xylanases Oxidases Pectinases

Proteases Tannase

SUCCESS MANTRA

DeterminationWillingness to take risk

Talented team Spirit of Adventure

MissionTo be an integrated biotechnology enterprise of global distinction.

Essential to this mission is excellence in: - Intellectual asset creation through discovery, research and development - State-of-the-art manufacturing capabilities - Internationally benchmarked quality and regulatory systems - New medical insight through disease specific clinical research - Customer relationship through outstanding products and services - Human resource development through training, mentoring and empowering - Management of research and business partnerships

Leadership style of the Kiran Mazumdar Shaw:

Kiran Mazumdar Shaw inspires her team with ashared vision of the future.

Transformed them into, and efficient workforce, She doesn't necessarily lead from the front, asshe loves to delegate responsibility amongst their teams. can need to be supported by people.

While their enthusiasm is often infectious, they

Transactional & Transformational LeadershipIn Biocon, both transactional and transformational leadership has been seen. The transactional leaders (or managers) ensure that routine work is done reliably, while the transformational leaders look after initiatives that add value.

High regulating and low nurturing has seen as the key factor ofher behavior, she always defines the role of the group members telling them what task to do and how and when and where to do them. She is the master of her field so she has developed her trade like that.

ContShe always initiates the problem solving and decision making; even the solution and decision are announced by her and its implementations are closely supervised. The above behavior keeps her under the authoritative and directive leadership trade. Kiran Mazumdar Shaw is known for her authority under her leadership. Biocon has immerged as the most admired company in biotechnology for their research work and wealth creation. She is the great believer in herself and always led the research project under her umbrella.

StrategiesNo commodity production in beginning due to lack ofinfrastructure Diversification rather than expansion Formed Helix(antibiotic prod.) Formed Syngene, Clinigene (R&D in fermentation) Biocon Quest(BQ)to produce these products in mass

Marketing strategyEnzymes produced & sold as industrial intermediaries (stayingwith buyers processing line helping them obtain desired result from the enzyme). Created an image of a reliable company able to give highly competent technical products & support Also custom based products at any level

She has never had to compromise or set aside her She has never stooped to corruption as she have

Business ethics

principles whether it was dealing with government, banks or international organizations. handled matters directly with the concerned officials. a driving force to achieve dreams and goals combined with a sense of commitment to society mark her as an extraordinary woman. is a role model for many women.

She has given Equal opportunity to all, hard work and

Combining technology and a woman's sensitivity, she

HR Policies Nirupa Bareja, group head (HR), Biocon says, "rateof attrition among women is marginally (0.1 percent) lower than men in the company. Stability factor: married women who rarely leave us. Also our HR practices help us in retaining most of the employees."

Innovative HR policies: For instance, new recruits

across all levels wear a badge that says - Hi I'M New - helping other employees recognize them and make them feel at home.

Challenges as a leader When she started biocon, it was a virgin territory andno one had heard of biotechnology. It was good for someone like her who is experimental and accidental entrepreneur. Her company began making Pepin, which was a plant enzyme from papaya, but Pepin was a low technology program and she wanted to go beyond that. She decided to create a very strong research engine as an integral part of the business.

LEADERSHIP QUALITIES AND LEADERSHIP STYLESMs. Shaw displayed leadership by demonstrating theimportance of acknowledging the efforts of the entire sales force irrespective of whether they met their targets. It brings in team spirit and a collective celebration of success.

Conti Developing novel enzymes, microbial enzymes for

various industrial applications excited her.

She and her Irish partner agreed and put together aR&D division, the first ever in India.

Through this they, created exciting opportunities forscientists in India, and they would not have to go abroad.

Decision makingHer decision making styles are a mix ofauthoritative and consultative.

She is known for her authority, at the same time afirm believer in team work.

Situational LeadershipA devastating situation Personal vs Professional life.

Biocon was busy negotiating with Danish firmNovozymes for the sale of its enzyme business.

Her husband John Shaw was diagnosed with acancerous lump in his throat.

Ms. Shaw tended too her husband in the hospitaland made strategic decisions for the deal which was a great success.

Personality Traits-Openness to experience - Very High - Extraversion - High - Agreeableness - High - Emotional Intelligence - High - Conscientiousness - Very High

Evil face of Kiran Mazumdar ShawExport of banned drug intermediate from china. Defaming Brand India by violating contracts. Started ABLE just for benefit of Biocon. Trying to monopolize biotech industry in India.

Lines by: Kiran Mazumdar ShawIf I can build a company like Biocon, anyone canThe first step was to dream however big or small.If you have a vision, no matter how big or small, a plan, no matter if it is imperfect, but if there is passion and conviction for it, success is inevitable.

Her vision for the future is to grow into a global bio-therapeutics company with very innovative and proprietary products and technologies

Thank you!